Revenue Growth Across the Portfolio
Kenvue grew total revenue by 4.5% YoY to $3.91B in Q1 2026 (vs. $3.74B in Q1 2025), reflecting continued consumer demand for its self-care and consumer health brands despite a challenging macro environment.
Kenvue Inc. is expected to release its Q2 2026 10-Q filing in the upcoming earnings season. Last quarter: Kenvue (KVUE) delivered a strong Q1 2026 with revenue up 4.5% YoY to $3.91B, while operating income surged 37.5% and net income jumped 47.2% to $474M, driven by significant cost discipline and margin expansion.
Drawn from management commentary in the Q1 2026 10-Q:
Kenvue grew total revenue by 4.5% YoY to $3.91B in Q1 2026 (vs. $3.74B in Q1 2025), reflecting continued consumer demand for its self-care and consumer health brands despite a challenging macro environment.
Gross margin improved approximately 94 basis points YoY to 58.9%, while operating margin expanded dramatically by ~470 basis points to 19.6%, indicating strong operating leverage and cost efficiency improvements.
SG&A expenses declined 5.5% YoY to $1.45B and R&D expenses fell 15.2% YoY to $84M, together contributing meaningfully to the operating income surge of 37.5% to $767M.
Revenue
$3.91B
++4.49% YoY
EPS (Basic)
$0.25
++47.06% YoY
Gross Margin
58.9%
++0.94% YoY
Operating Income
$767M
++37.46% YoY
Add KVUE to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.